caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1982002028

Michelle Kallevik

PRACTICEOPTOMEYES HEALTH PCSee all providers at this practice →
Nurse PractitionerDartmouth, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Michelle Kallevik's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 18 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
German Velasco
Endocrinology · Middleboro, MA
233452
Quest Diagnostics Massachusetts Llc
Clinical Laboratory · Marlborough, MA
124226
SOUTHCOAST HOSPITALS GROUP, INC79180
Anna Kozupa
Endocrinology · Dartmouth, MA
55119
Laurie Davignon
Nurse Practitioner · South Burlington, VT
50112
NPI 11341951912276
Daniel Weller
Diagnostic Radiology · New Bedford, MA
1934
Gloriane Afonso-Fede
Internal Medicine · Dartmouth, MA
1846
Jonathan Bojarski
Diagnostic Radiology · Boston, MA
1622
Roger Rosen
Vascular Surgery · Hyannis, MA
1523
David Shih
Internal Medicine · North Dartmouth, MA
1544
Jordan Gularek
Internal Medicine · Dartmouth, MA
1550
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
86
Beneficiaries
—
Total drug cost
$9K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Buprenorphine Hcl/Naloxone Hcl86 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.